Science
An efficient, mini CRISPR system engineered – Tech Explorist
Its diminutive size should make it easier to deliver into human cells, tissues and the body for gene therapy.
Many CRISPR gene editing systems are currently being used for various gene therapy. Although, those systems have limited scope because they are too large and too hard to deliver into cells, tissues, or living organisms.
In a new study, bioengineers at Stanford…
Continue Reading
-
Business21 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoWilliam Robinson dies aged 89
-
Noosa News18 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89
-
Business22 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts